ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend
February 13, 2025
13 Feb 2025

Acarix AB (publ) Publishes Year-End Report 2024 – Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts

Malmö — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial res...
Continue reading
author-avatar
Interim, IR, Listing Regulation, News, Q3, Regulatory, Report, Swedish
November 18, 2024
07 Nov 2024

Acarix AB (publ) publicerar tredje kvartalet 2024

Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat för det tredje ...
Continue reading
author-avatar
English, Interim, IR, Listing Regulation, News, Q3, Regulatory, Report
November 18, 2024
07 Nov 2024

Acarix Publishes Third Quarter 2024 Report

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 202...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
01 Oct 2024

Acarix resolves on a directed issue to the guarantors of the warrant series 3

Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
26 Sep 2024

Acarix announces outcome of warrant exercise of series 3

Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
11 Sep 2024

Acarix informs of exercise price for the warrants of series TO 3

Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...
Continue reading
author-avatar
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
28 Aug 2024

Acarix receives additional declaration of intent and fully secures the warrants of series TO 3 through guarantee agreements

Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the Company has rec...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
26 Aug 2024

Acarix receives declarations of intent to exercise warrants of series TO 3

Acarix AB ("Acarix" or the "Company") has received declarations of intent to exercise Warrants of series TO 3 (the "Warrants") from a n...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report
November 18, 2024
22 Aug 2024

Acarix AB (publ) publishes Interim Report, April – June 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
03 Jul 2024

ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF SEK 21 MILLION

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BE...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
03 Jul 2024

ACARIX GENOMFÖR EN RIKTAD EMISSION OM 21 MSEK

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, DISTRIBUERAS ELLER PUBLICERAS, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL ...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
14 May 2024

Announcement from the annual general meeting in Acarix AB

The annual general meeting 2024 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 14 May 2024 and the following re...
Continue reading
  • 1
  • 2
  • 3
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.